Seoul Pharma Co., Ltd (KOSDAQ:018680)
South Korea · Delayed Price · Currency is KRW 2,405.00
-30.00 (-1.23%)
At close: May 29, 2026
Seoul Pharma Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 725.89 | 753.64 | 1,699 | 3,517 | 855.09 | -9,689 |
Depreciation & Amortization | 2,663 | 2,662 | 2,490 | 1,928 | 2,613 | 2,528 |
Loss (Gain) From Sale of Assets | 1.78 | 1.78 | 0.05 | 8.26 | 0.02 | 0.01 |
Asset Writedown & Restructuring Costs | - | - | - | - | 2,177 | 198.8 |
Loss (Gain) From Sale of Investments | - | - | -67.49 | -63.71 | - | - |
Provision & Write-off of Bad Debts | 17.23 | 24.64 | -14.53 | -6.14 | -9.64 | 24.12 |
Other Operating Activities | 552.01 | 944.03 | 1,549 | 2,270 | -207.94 | 4,898 |
Change in Accounts Receivable | 4,597 | 631.55 | -4,071 | -111.42 | -381.62 | -1,261 |
Change in Inventory | 1,452 | 523.9 | -1,623 | -1,920 | -2,769 | 270.5 |
Change in Accounts Payable | -407.65 | -469.53 | -410.48 | -164.12 | 1,020 | 1,173 |
Change in Other Net Operating Assets | 1,269 | -3,186 | -2,559 | -193.42 | -3,375 | 181.78 |
Operating Cash Flow | 10,953 | 1,886 | -3,008 | 5,265 | -78.21 | -1,675 |
Capital Expenditures | -910.37 | -861.26 | -2,229 | -1,893 | -1,233 | -1,157 |
Sale (Purchase) of Intangibles | -31.85 | -32.46 | -0.7 | -1.52 | -66.23 | -10.71 |
Investment in Securities | 979.26 | - | 3,146 | -4,023 | - | 3.18 |
Other Investing Activities | 60.75 | 50.75 | 540.74 | 55 | -33 | 1 |
Investing Cash Flow | 97.79 | -842.97 | 1,457 | -5,862 | -1,332 | -1,099 |
Short-Term Debt Issued | - | 2,000 | 3,000 | - | 4,000 | 4,000 |
Long-Term Debt Issued | - | - | 10,000 | - | - | 10,000 |
Total Debt Issued | 2,000 | 2,000 | 13,000 | - | 4,000 | 14,000 |
Short-Term Debt Repaid | - | - | - | -4,000 | -4,000 | -2,000 |
Long-Term Debt Repaid | - | -672.39 | -10,620 | -465.7 | -474.25 | -10,465 |
Total Debt Repaid | -634.03 | -672.39 | -10,620 | -4,466 | -4,474 | -12,465 |
Net Debt Issued (Repaid) | 1,366 | 1,328 | 2,380 | -4,466 | -474.25 | 1,535 |
Other Financing Activities | -0 | -0 | -0 | - | -8.94 | -0 |
Financing Cash Flow | 1,366 | 1,328 | 2,380 | -4,466 | -483.19 | 1,535 |
Foreign Exchange Rate Adjustments | 47.48 | 38.05 | 138.15 | -91.7 | -198.35 | 1.74 |
Net Cash Flow | 12,464 | 2,408 | 966.43 | -5,155 | -2,092 | -1,237 |
Free Cash Flow | 10,042 | 1,025 | -5,237 | 3,372 | -1,311 | -2,831 |
Free Cash Flow Margin | 19.56% | 1.97% | -9.78% | 6.43% | -2.62% | -7.00% |
Free Cash Flow Per Share | - | 87.87 | -449.20 | 289.20 | -146.00 | -332.16 |
Cash Interest Paid | 625.2 | 570.07 | 427.49 | 442.51 | 491.88 | 457.9 |
Cash Income Tax Paid | 213.19 | 188.68 | 11.53 | 4.36 | 31.28 | 165.54 |
Levered Free Cash Flow | 8,938 | -5.64 | -7,405 | -524.76 | -2,459 | 1,277 |
Unlevered Free Cash Flow | 9,299 | 355.16 | -7,129 | -248.19 | -1,757 | 1,984 |
Change in Working Capital | 6,992 | -2,500 | -8,663 | -2,389 | -5,506 | 364.94 |